Insulin aspart, recombinant Subcutaneous and Leader Acid Control
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Leader Acid Control and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ranitidine
Brand name: Zantac
Synonyms: Ranitidine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Leader Acid Reducer Maximum Strength
- Insulin aspart, recombinant Subcutaneous-Leader All Day Allergy
- Insulin aspart, recombinant Subcutaneous-Leader Allergy D 12
- Insulin aspart, recombinant Subcutaneous-Leader Allergy Relief
- Insulin aspart, recombinant Subcutaneous-Leader Allergy Relief D-24
- Insulin aspart, recombinant Subcutaneous-Leader Allerhist
- Leader Acid Control-Insulin degludec
- Leader Acid Control-Insulin Degludec (U-100) Prefilled Pens
- Leader Acid Control-Insulin Degludec (U-100) Vials
- Leader Acid Control-Insulin Degludec (U-200) Prefilled Pens
- Leader Acid Control-Insulin degludec and liraglutide
- Leader Acid Control-Insulin degludec and liraglutide Subcutaneous